Kratom laws in Colorado

18-13-132.  Furnishing kratom products to persons under
twenty-one years of age.  (1) (a)  A  PERSON SHALL NOT GIVE , SELL ,
DISTRIBUTE, DISPENSE , OR OFFER FOR SALE A KRATOM PRODUCT TO ANY
PERSON WHO IS UNDER TWENTY-ONE YEARS OF AGE.
(b)  B EFORE GIVING , SELLING , DISTRIBUTING , DISPENSING , OR
OFFERING TO SELL TO AN INDIVIDUAL ANY KRATOM PRODUCT , A PERSON
SHALL REQUEST FROM THE INDIVIDUAL AND EXAMINE A
GOVERNMENT-ISSUED PHOTOGRAPHIC IDENTIFICATION THAT ESTABLISHES
THAT THE INDIVIDUAL IS TWENTY-ONE YEARS OF AGE OR OLDER.
...
(2) (a)  NOTHING IN THIS SECTION PROHIBITS A STATUTORY OR HOME
RULE MUNICIPALITY, COUNTY, OR CITY AND COUNTY FROM ENACTING AN
ORDINANCE OR RESOLUTION THAT PROHIBITS THE SALE OF ANY KRATOM
PRODUCTS TO PERSONS UNDER TWENTY -ONE YEARS OF AGE OR IMPOSES
REQUIREMENTS MORE STRINGENT THAN PROVIDED IN THIS SECTION.
(b)  A STATUTORY OR HOME RULE MUNICIPALITY, COUNTY, OR CITY
AND COUNTY SHALL NOT ENACT AN ORDINANCE OR RESOLUTION THAT
ESTABLISHES A MINIMUM AGE TO PURCHASE KRATOM PRODUCTS THAT IS
UNDER TWENTY-ONE YEARS OF AGE.

SECTION 2.   In Colorado Revised Statutes, add 6-1-740 as
follows:
6-1-740.  Kratom - deceptive trade practice - definitions. (1)  AS
USED IN THIS SECTION, UNLESS THE CONTEXT OTHERWISE REQUIRES:
...
(f)  "KRATOM PRODUCT" MEANS A FOOD OR DIETARY SUPPLEMENT
THAT CONSISTS OF, OR CONTAINS, ANY PART OF A KRATOM LEAF, A KRATOM
LEAF EXTRACT , OR ANY KRATOM ALKALOID , KRATOM CONSTITUENT , OR
KRATOM METABOLITE AND DOES NOT INCLUDE ANY SYNTHESIZED
ALKALOIDS OR SEMI-SYNTHESIZED ALKALOIDS.
...
(2)  A PERSON SHALL NOT:
(a)  KNOWINGLY PREPARE, DISTRIBUTE, ADVERTISE, SELL, OR OFFER
TO SELL A KRATOM PRODUCT:
(I)  THAT IS ADULTERATED;
(II)  TO A PERSON UNDER TWENTY-ONE YEARS OF AGE;
(III)  THAT CONTAINS A LEVEL OF 7-HYDROXYMITRAGYNINE IN THE
ALKALOID FRACTION THAT IS GREATER THAN TWO PERCENT OF THE
ALKALOID COMPOSITION OF THE KRATOM PRODUCT;
(IV)  T HAT IS A CONFECTION ; MIMICS A CANDY PRODUCT ; OR IS
MANUFACTURED, PACKAGED, LABELED, OR DISTRIBUTED IN A WAY THAT IS
APPEALING TO CHILDREN, INCLUDING IN THE DISTINCT SHAPE OF A HUMAN,
AN ANIMAL, OR FRUIT; OR
(V)  THAT IS COMBUSTIBLE OR INTENDED FOR VAPORIZATION;
...
(d)  M ANUFACTURE, PACKAGE, LABEL, OR DISTRIBUTE A KRATOM
PRODUCT THAT:
(I)  C ONTAINS SYNTHESIZED ALKALOIDS OR SEMI -SYNTHESIZED
ALKALOIDS; OR
(II)  H AS A LEVEL OF 7-HYDROXYMITRAGYNINE IN THE ALKALOID
FRACTION THAT IS GREATER THAN TWO PERCENT OF THE ALKALOID
COMPOSITION OF THE PRODUCT.
(3)  A  PERSON THAT CONDUCTS THE ACTIVITIES DESCRIBED IN
SUBSECTION (2) OF THIS SECTION ENGAGES IN A DECEPTIVE TRADE PRACTICE.

(2)  A PERSON SHALL NOT:
(a)  KNOWINGLY PREPARE, DISTRIBUTE, ADVERTISE, SELL, OR OFFER
TO SELL A KRATOM PRODUCT:
...
(IV)  T HAT IS A CONFECTION ; MIMICS A CANDY PRODUCT ; OR IS
MANUFACTURED, PACKAGED, LABELED, OR DISTRIBUTED IN A WAY THAT IS
APPEALING TO CHILDREN, INCLUDING IN THE DISTINCT SHAPE OF A HUMAN,
AN ANIMAL, OR FRUIT; OR
(V)  THAT IS COMBUSTIBLE OR INTENDED FOR VAPORIZATION;

(89) Methyl (E)-2-((1'S,6'S,7'S)-6'-ethyl-4-methoxy-3-oxo- 9672
3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-2,1'-
indolizine]-7'-yl)-3-methoxyacrylate (commonly known as
mitragynine pseudoindoxyl) including its isomers, esters,
...
(90) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8- 9673
...
15; also known as dihydro-7-hydroxymitragynine) including its
...
(91) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a- 9674
...
(commonly known as MGM-16; also known as 9-fluoro-dihydro-7-
hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine

The substances [7-hydroxymitragynine] and [mitragynine
pseudoindoxyl] be controlled in schedule I [pursuant to 21 U.S.C.
811(h)] when either substance alone, or their combined amount if both
present, is:
(A) Above a specified threshold concentration, that is, greater
than 1 mg per gram (for solid powders, encapsulated material, or other
solid forms) or greater than 1 mg per milliliter (for liquid
preparations), OR
(B) The mass of mitragynine present divided by the mass of [7-
hydroxymitragynine], or [mitragynine pseudoindoxyl], or the combined
amount of [7-hydroxymitragynine] and [mitragynine pseudoindoxyl] if
both present, is less than 100.
...
The temporary scheduling order will be published in the Federal
Register on or after November 13, 2026.